Bertin Nahum

Co-Founder & CEO of Quantum Surgical - Leadership Excellence in Medical Technology

Profile

Bertim Nahun is a successful entrepreneur in Surgical Robotics.

Prior to Quantum Surgical, Bertin founded Medtech SA (Rosa Surgical Robot – neuro and spine surgery) in 2002, took the company public (IPO) in 2013 and sold it to Zimmer Biomet (NYSE: ZBH) in 2016.

Previously, he pioneered the development of robot-assisted solutions in various surgical specialties at Computer Motion Inc. (Zeus, AESOP – laparoscopic surgery) and Integrated Surgical Systems Inc. (ROBODOC – orthopedic surgery).

Bertin Nahum graduated from the National Institute of Applied Sciences (FR) and holds a Master of Science in Robotics and a Doctorate of Technology Honoris Causa from Coventry University (UK).

FIRM PROFILE

Our journey begins with lung, liver, kidney and pancreatic cancers which are one of the leading causes of cancer deaths worldwide.

While more than 6 million new abdominal and lung cancers are diagnosed every year, Quantum Surgical’s purpose is to offer an innovative approach to cancer treatment, accessible to a wider population, allowing more patients to benefit from state-of-the-art, more targeted, and less invasive treatments.

We aim to set new standards in cancer treatment by enabling more patients to benefit from better-targeted and less invasive treatments.

To achieve this goal, Quantum Surgical has developed the Epione robot, dedicated to the curative and early treatment of cancers. It enables physicians to treat tumors that are inoperable or particularly difficult to reach, due to their size or their location, at an early stage without surgical intervention, in a simple and effective manner.

Relying on the know-how of the physician, our Epione robotic platform can treat inoperable tumors in the abdomen and the lungs.

Our key strategic pillars:
Innovation
We leveraged an extensive medical robotics background in orthopedics, neurosurgery and spine to deliver innovation in Interventional Oncology.
Medical Robotics
We are focused on designing technology which will overcome current challenges, expand physician capabilities and help standardize treatments.

Interventional Oncology
Our goal is to transform medical intervention and provide access to cancer treatment in the least invasive manner possible.

Epione
An innovative solution for interventional oncology, Epione is a robotic-assisted technology to plan, target, deliver and confirm tumor ablation.

Using the power of robotics and image fusion technology, Epione provides clinicians the ability to target challenging tumors.

The Epione device is CE marked for abdomen and lung indications, and FDA cleared for abdominal ablation indication

Epione is an open robotic solution compatible with most commonly used imaging systems. The medical robot is designed to allow physicians to treat with their preferred ablative technologies (radiofrequency, microwave, cryoablation, irreversible electroporation) so they can decide the right therapy for each individual patient.

Our goal is to dramatically ease multiple probe procedures which will make treatment of large tumors more predictable.